Literature DB >> 24698108

The Lymphotoxin Network: orchestrating a type I interferon response to optimize adaptive immunity.

Jennifer L Gommerman1, Jeffrey L Browning2, Carl F Ware3.   

Abstract

The Lymphotoxin (LT) pathway is best known for its role in orchestrating the development and homeostasis of lymph nodes and Peyer's patches through the regulation of homeostatic chemokines. More recently an appreciation of the LTβR pathway in the production of Type I interferons (IFN-I) during homeostasis and infection has emerged. LTβR signaling is essential in differentiating stromal cells and macrophages in lymphoid organs to rapidly produce IFN-I in response to virus infections independently of the conventional TLR signaling systems. In addition, LTβR signaling is required to produce homeostatic levels of IFN-I from dendritic cells in order to effectively cross-prime a CD8+ T cell response to protein antigen. Importantly, pharmacological inhibition of LTβR signaling in mice has a profound positive impact on a number of autoimmune disease models, although it remains unclear if this efficacy is linked to IFN-I production during chronic inflammation. In this review, we will provide a brief overview of how the "Lymphotoxin Network" is linked to the IFN-I response and its impact on the immune system.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Autoimmunity; Dendritic cells; Interferon (IFN); Lymphotoxin-αβ (LTαβ); Stromal cells

Mesh:

Substances:

Year:  2014        PMID: 24698108      PMCID: PMC4081445          DOI: 10.1016/j.cytogfr.2014.02.002

Source DB:  PubMed          Journal:  Cytokine Growth Factor Rev        ISSN: 1359-6101            Impact factor:   7.638


  80 in total

1.  A role for surface lymphotoxin in experimental autoimmune encephalomyelitis independent of LIGHT.

Authors:  Jennifer L Gommerman; Keith Giza; Stuart Perper; Irene Sizing; Apinya Ngam-Ek; Cheryl Nickerson-Nutter; Jeffrey L Browning
Journal:  J Clin Invest       Date:  2003-09       Impact factor: 14.808

Review 2.  Lymphoid organ development and cell migration.

Authors:  Jason G Cyster
Journal:  Immunol Rev       Date:  2003-10       Impact factor: 12.988

3.  Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon.

Authors:  Agnes Le Bon; Nathalie Etchart; Cornelia Rossmann; Miranda Ashton; Sam Hou; Dirk Gewert; Persephone Borrow; David F Tough
Journal:  Nat Immunol       Date:  2003-09-21       Impact factor: 25.606

Review 4.  Lymphotoxin/light, lymphoid microenvironments and autoimmune disease.

Authors:  Jennifer L Gommerman; Jeffrey L Browning
Journal:  Nat Rev Immunol       Date:  2003-08       Impact factor: 53.106

5.  Constitutive expression of LIGHT on T cells leads to lymphocyte activation, inflammation, and tissue destruction.

Authors:  R B Shaikh; S Santee; S W Granger; K Butrovich; T Cheung; M Kronenberg; H Cheroutre; C F Ware
Journal:  J Immunol       Date:  2001-12-01       Impact factor: 5.422

6.  The regulation of T cell homeostasis and autoimmunity by T cell-derived LIGHT.

Authors:  J Wang; J C Lo; A Foster; P Yu; H M Chen; Y Wang; K Tamada; L Chen; Y X Fu
Journal:  J Clin Invest       Date:  2001-12       Impact factor: 14.808

7.  Blockade of LIGHT/LTbeta and CD40 signaling induces allospecific T cell anergy, preventing graft-versus-host disease.

Authors:  Koji Tamada; Hideto Tamura; Dallas Flies; Yang-Xin Fu; Esteban Celis; Larry R Pease; Bruce R Blazar; Lieping Chen
Journal:  J Clin Invest       Date:  2002-02       Impact factor: 14.808

8.  Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1.

Authors:  Mehrdad Matloubian; Charles G Lo; Guy Cinamon; Matthew J Lesneski; Ying Xu; Volker Brinkmann; Maria L Allende; Richard L Proia; Jason G Cyster
Journal:  Nature       Date:  2004-01-22       Impact factor: 49.962

9.  Lymphotoxin beta receptor-Ig fusion protein treatment blocks actively induced, but not adoptively transferred, uveitis in Lewis rats.

Authors:  Hui Shao; Yangxin Fu; Lei Song; Sheher Sun; Herry J Kaplan; Deming Sun
Journal:  Eur J Immunol       Date:  2003-06       Impact factor: 5.532

10.  A role for the lymphotoxin/LIGHT axis in the pathogenesis of murine collagen-induced arthritis.

Authors:  Roy A Fava; Evangelia Notidis; Jane Hunt; Veronika Szanya; Nora Ratcliffe; Apinya Ngam-Ek; Antonin R De Fougerolles; Andrew Sprague; Jeffrey L Browning
Journal:  J Immunol       Date:  2003-07-01       Impact factor: 5.422

View more
  19 in total

1.  Interferon-induced mechanosensing defects impede apoptotic cell clearance in lupus.

Authors:  Hao Li; Yang-Xin Fu; Qi Wu; Yong Zhou; David K Crossman; PingAr Yang; Jun Li; Bao Luo; Laurence M Morel; Janusz H Kabarowski; Hideo Yagita; Carl F Ware; Hui-Chen Hsu; John D Mountz
Journal:  J Clin Invest       Date:  2015-06-22       Impact factor: 14.808

2.  Realigning the LIGHT signaling network to control dysregulated inflammation.

Authors:  Carl F Ware; Michael Croft; Garry A Neil
Journal:  J Exp Med       Date:  2022-05-23       Impact factor: 17.579

3.  Targeting an alternate Wilms' tumor antigen 1 peptide bypasses immunoproteasome dependency.

Authors:  Miranda C Lahman; Thomas M Schmitt; Kelly G Paulson; Nathalie Vigneron; Denise Buenrostro; Felecia D Wagener; Valentin Voillet; Lauren Martin; Raphael Gottardo; Jason Bielas; Julie M McElrath; Derek L Stirewalt; Era L Pogosova-Agadjanyan; Cecilia C Yeung; Robert H Pierce; Daniel N Egan; Merav Bar; Paul C Hendrie; Sinéad Kinsella; Aesha Vakil; Jonah Butler; Mary Chaffee; Jonathan Linton; Megan S McAfee; Daniel S Hunter; Marie Bleakley; Anthony Rongvaux; Benoit J Van den Eynde; Aude G Chapuis; Philip D Greenberg
Journal:  Sci Transl Med       Date:  2022-02-09       Impact factor: 19.319

Review 4.  Lymphotoxin in physiology of lymphoid tissues - Implication for antiviral defense.

Authors:  Ekaterina P Koroleva; Yang-Xin Fu; Alexei V Tumanov
Journal:  Cytokine       Date:  2016-09-09       Impact factor: 3.861

Review 5.  The TNF Receptor Superfamily in Co-stimulating and Co-inhibitory Responses.

Authors:  Lindsay K Ward-Kavanagh; Wai Wai Lin; John R Šedý; Carl F Ware
Journal:  Immunity       Date:  2016-05-17       Impact factor: 31.745

6.  Identification of a Distal Locus Enhancer Element That Controls Cell Type-Specific TNF and LTA Gene Expression in Human T Cells.

Authors:  Luke D Jasenosky; Aya Nambu; Alla V Tsytsykova; Shahin Ranjbar; Viraga Haridas; Laurens Kruidenier; David F Tough; Anne E Goldfeld
Journal:  J Immunol       Date:  2020-09-25       Impact factor: 5.422

7.  Lymphotoxin-LIGHT pathway regulates the interferon signature in rheumatoid arthritis.

Authors:  Jadwiga Bienkowska; Norm Allaire; Alice Thai; Jaya Goyal; Tatiana Plavina; Ajay Nirula; Megan Weaver; Charlotte Newman; Michelle Petri; Evan Beckman; Jeffrey L Browning
Journal:  PLoS One       Date:  2014-11-18       Impact factor: 3.240

8.  LTβR signalling preferentially accelerates oncogenic AKT-initiated liver tumours.

Authors:  Anthony J Scarzello; Qun Jiang; Timothy Back; Hien Dang; Deborah Hodge; Charlotte Hanson; Jeffrey Subleski; Jonathan M Weiss; Jimmy K Stauffer; Jitti Chaisaingmongkol; Siritida Rabibhadana; Mathuros Ruchirawat; John Ortaldo; Xin Wei Wang; Paula S Norris; Carl F Ware; Robert H Wiltrout
Journal:  Gut       Date:  2015-07-23       Impact factor: 23.059

Review 9.  Epidemiology of Sjögren's Syndrome-from an Oral Perspective.

Authors:  Anne Isine Bolstad; Kathrine Skarstein
Journal:  Curr Oral Health Rep       Date:  2016-09-02

Review 10.  Lymphotoxin: from the physiology to the regeneration of the thymic function.

Authors:  Alexia Borelli; Magali Irla
Journal:  Cell Death Differ       Date:  2021-07-22       Impact factor: 12.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.